Lineage Cell (Israel) Price Prediction

BTX Stock  ILS 550.90  63.60  13.05%   
The value of RSI of Lineage Cell's the stock price is about 63 suggesting that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Lineage, making its price go up or down.

Oversold Vs Overbought

63

 
Oversold
 
Overbought
Lineage Cell Therapeutics stock price prediction is an act of determining the future value of Lineage Cell shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Lineage Cell's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Lineage Cell and does not consider all of the tangible or intangible factors available from Lineage Cell's fundamental data. We analyze noise-free headlines and recent hype associated with Lineage Cell Therapeutics, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Lineage Cell based on different types of headlines from major news networks to social media. The Lineage stock price prediction module provides an analysis of price elasticity to changes in media outlook on Lineage Cell over a specific investment horizon. Using Lineage Cell hype-based prediction, you can estimate the value of Lineage Cell Therapeutics from the perspective of Lineage Cell response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Lineage Cell. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Lineage Cell to buy its stock at a price that has no basis in reality. In that case, they are not buying Lineage because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Lineage Cell after-hype prediction price

    
  ILA 550.9  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Lineage Cell Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lineage Cell's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
414.57419.96605.99
Details
Naive
Forecast
LowNextHigh
515.48520.87526.26
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
418.99488.42557.85
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Lineage Cell. Your research has to be compared to or analyzed against Lineage Cell's peers to derive any actionable benefits. When done correctly, Lineage Cell's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Lineage Cell Therapeutics.

Lineage Cell After-Hype Price Prediction Density Analysis

As far as predicting the price of Lineage Cell at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lineage Cell or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lineage Cell, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Lineage Cell Estimiated After-Hype Price Volatility

In the context of predicting Lineage Cell's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lineage Cell's historical news coverage. Lineage Cell's after-hype downside and upside margins for the prediction period are 545.51 and 556.29, respectively. We have considered Lineage Cell's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
550.90
545.51
Downside
550.90
After-hype Price
556.29
Upside
Lineage Cell is very steady at this time. Analysis and calculation of next after-hype price of Lineage Cell Therapeutics is based on 3 months time horizon.

Lineage Cell Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Lineage Cell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lineage Cell backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lineage Cell, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.45 
5.39
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
550.90
550.90
0.00 
0.00  
Notes

Lineage Cell Hype Timeline

Lineage Cell Therapeutics is currently traded for 550.90on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Lineage is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.45%. %. The volatility of related hype on Lineage Cell is about 0.0%, with the expected price after the next announcement by competition of 550.90. The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Lineage Cell Therapeutics had not issued any dividends in recent years. Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days.
Check out Lineage Cell Basic Forecasting Models to cross-verify your projections.

Lineage Cell Related Hype Analysis

Having access to credible news sources related to Lineage Cell's direct competition is more important than ever and may enhance your ability to predict Lineage Cell's future price movements. Getting to know how Lineage Cell rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lineage Cell may potentially react to the hype associated with one of its peers.

Lineage Cell Additional Predictive Modules

Most predictive techniques to examine Lineage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lineage using various technical indicators. When you analyze Lineage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Lineage Cell Predictive Indicators

The successful prediction of Lineage Cell stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lineage Cell Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lineage Cell based on analysis of Lineage Cell hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lineage Cell's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lineage Cell's related companies.

Story Coverage note for Lineage Cell

The number of cover stories for Lineage Cell depends on current market conditions and Lineage Cell's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lineage Cell is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lineage Cell's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
When determining whether Lineage Cell Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lineage Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lineage Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lineage Cell Therapeutics Stock:
Check out Lineage Cell Basic Forecasting Models to cross-verify your projections.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Lineage Stock analysis

When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Please note, there is a significant difference between Lineage Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lineage Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lineage Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.